These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

343 related items for PubMed ID: 1638688

  • 1. Mechanisms associated with the expression of cisplatin resistance in a human ovarian tumor cell line following exposure to fractionated X-irradiation in vitro.
    Dempke WC, Shellard SA, Hosking LK, Fichtinger-Schepman AM, Hill BT.
    Carcinogenesis; 1992 Jul; 13(7):1209-15. PubMed ID: 1638688
    [Abstract] [Full Text] [Related]

  • 2. Characterization of a cisplatin-resistant human ovarian carcinoma cell line expressing cross-resistance to 5-fluorouracil but collateral sensitivity to methotrexate.
    Hill BT, Shellard SA, Hosking LK, Dempke WC, Fichtinger-Schepman AM, Tone T, Scanlon KJ, Whelan RD.
    Cancer Res; 1992 Jun 01; 52(11):3110-8. PubMed ID: 1591724
    [Abstract] [Full Text] [Related]

  • 3. Enhanced DNA repair and tolerance of DNA damage associated with resistance to cis-diammine-dichloroplatinum (II) after in vitro exposure of a human teratoma cell line to fractionated X-irradiation.
    Hill BT, Shellard SA, Hosking LK, Fichtinger-Schepman AM, Bedford P.
    Int J Radiat Oncol Biol Phys; 1990 Jul 01; 19(1):75-83. PubMed ID: 2380098
    [Abstract] [Full Text] [Related]

  • 4. Expression of collateral sensitivity to cisplatin, methotrexate, and fluorouracil in a human ovarian carcinoma cell line following exposure to fractionated x-irradiation in vitro.
    Dempke WC, Hosking LK, Hill BT.
    Semin Oncol; 1992 Apr 01; 19(2 Suppl 3):66-72. PubMed ID: 1557659
    [Abstract] [Full Text] [Related]

  • 5. Anomalous relationship between cisplatin sensitivity and the formation and removal of platinum-DNA adducts in two human ovarian carcinoma cell lines in vitro.
    Shellard SA, Hosking LK, Hill BT.
    Cancer Res; 1991 Sep 01; 51(17):4557-64. PubMed ID: 1873800
    [Abstract] [Full Text] [Related]

  • 6. Characterisation of the unusual expression of cross resistance to cisplatin in a series of etoposide-selected resistant sublines of the SuSa testicular teratoma cell line.
    Shellard SA, Hosking LK, Hill BT.
    Biochem Pharmacol; 1994 Mar 02; 47(5):775-9. PubMed ID: 8135853
    [Abstract] [Full Text] [Related]

  • 7. The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell line.
    Meijer C, Mulder NH, Hospers GA, Uges DR, de Vries EG.
    Br J Cancer; 1990 Jul 02; 62(1):72-7. PubMed ID: 2390486
    [Abstract] [Full Text] [Related]

  • 8. Evidence of differential cisplatin-DNA adduct formation, removal and tolerance of DNA damage in three human lung carcinoma cell lines.
    Shellard SA, Fichtinger-Schepman AM, Lazo JS, Hill BT.
    Anticancer Drugs; 1993 Aug 02; 4(4):491-500. PubMed ID: 8400352
    [Abstract] [Full Text] [Related]

  • 9. Gene expression in X-irradiated human tumour cell lines expressing cisplatin resistance and altered DNA repair capacity.
    Taverna P, Hansson J, Scanlon KJ, Hill BT.
    Carcinogenesis; 1994 Sep 02; 15(9):2053-6. PubMed ID: 7923602
    [Abstract] [Full Text] [Related]

  • 10. Differential formation and enhanced removal of specific cisplatin-DNA adducts in two cisplatin-selected resistant human testicular teratoma sublines.
    Hill BT, Shellard SA, Fichtinger-Schepman AM, Schmoll HJ, Harstrick A.
    Anticancer Drugs; 1994 Jun 02; 5(3):321-8. PubMed ID: 7919457
    [Abstract] [Full Text] [Related]

  • 11. Deficient repair of cisplatin-DNA adducts identified in human testicular teratoma cell lines established from tumours from untreated patients.
    Hill BT, Scanlon KJ, Hansson J, Harstrick A, Pera M, Fichtinger-Schepman AM, Shellard SA.
    Eur J Cancer; 1994 Jun 02; 30A(6):832-7. PubMed ID: 7917544
    [Abstract] [Full Text] [Related]

  • 12. Pretreatment with 5-fluorouracil enhances cytotoxicity and retention of DNA-bound platinum in a cisplatin resistant human ovarian cancer cell line.
    Tanaka T, Masuda H, Naito M, Tamai H.
    Anticancer Res; 2001 Jun 02; 21(4A):2463-9. PubMed ID: 11724308
    [Abstract] [Full Text] [Related]

  • 13. Correlation of the response to cisplatin of human ovarian cancer cell lines, originating from one tumor but with different sensitivity, with the recovery of DNA adducts.
    De Pooter CM, Van Oosterom AT, Scalliet PG, Maes RA, de Bruijn EA.
    Biochem Pharmacol; 1996 Mar 08; 51(5):629-34. PubMed ID: 8615899
    [Abstract] [Full Text] [Related]

  • 14. Modulation of cisplatin resistance in acquired-resistant nonsmall cell lung cancer cells.
    Lai SL, Hwang J, Perng RP, Whang-Peng J.
    Oncol Res; 1995 Mar 08; 7(1):31-8. PubMed ID: 7549042
    [Abstract] [Full Text] [Related]

  • 15. Cellular basis for differential sensitivity to cisplatin in human germ cell tumour and colon carcinoma cell lines.
    Sark MW, Timmer-Bosscha H, Meijer C, Uges DR, Sluiter WJ, Peters WH, Mulder NH, de Vries EG.
    Br J Cancer; 1995 Apr 08; 71(4):684-90. PubMed ID: 7710929
    [Abstract] [Full Text] [Related]

  • 16. Multifactorial mechanisms associated with broad cross-resistance of ovarian carcinoma cells selected by cyanomorpholino doxorubicin.
    Lau DH, Lewis AD, Ehsan MN, Sikic BI.
    Cancer Res; 1991 Oct 01; 51(19):5181-7. PubMed ID: 1717140
    [Abstract] [Full Text] [Related]

  • 17. The formation and removal of cisplatin (CDDP) induced DNA adducts in a CDDP sensitive and resistant human small cell lung carcinoma (HSCLC) cell line.
    Hospers GA, de Vries EG, Mulder NH.
    Br J Cancer; 1990 Jan 01; 61(1):79-82. PubMed ID: 2153398
    [Abstract] [Full Text] [Related]

  • 18. JM216-, JM118-, and cisplatin-induced cytotoxicity in relation to platinum-DNA adduct formation, glutathione levels and p53 status in human tumour cell lines with different sensitivities to cisplatin.
    Fokkema E, Groen HJ, Helder MN, de Vries EG, Meijer C.
    Biochem Pharmacol; 2002 Jun 01; 63(11):1989-96. PubMed ID: 12093475
    [Abstract] [Full Text] [Related]

  • 19. Mechanisms of cross-resistance to methotrexate and 5-fluorouracil in an A2780 human ovarian carcinoma cell subline resistant to cisplatin.
    Newman EM, Lu Y, Kashani-Sabet M, Kesavan V, Scanlon KJ.
    Biochem Pharmacol; 1988 Feb 01; 37(3):443-7. PubMed ID: 3337743
    [Abstract] [Full Text] [Related]

  • 20. Effects of gemcitabine on cis-platinum-DNA adduct formation and repair in a panel of gemcitabine and cisplatin-sensitive or -resistant human ovarian cancer cell lines.
    Peters GJ, Van Moorsel CJ, Lakerveld B, Smid K, Noordhuis P, Comijn EC, Weaver D, Willey JC, Voorn D, Van der Vijgh WJ, Pinedo HM.
    Int J Oncol; 2006 Jan 01; 28(1):237-44. PubMed ID: 16328001
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.